WAT Waters Corporation

The Waters ACQUITY Arc System Receives 2016 Frost & Sullivan New Product Innovation Award

Today, Waters Corporation (NYSE:WAT) announced that its ACQUITY® Arc™ System received a 2016 New Product Innovation Award from market research and growth consulting firm Frost & Sullivan.

This Smart News Release features multimedia. View the full release here: http://www.businesswire.com/news/home/20161004005211/en/

Waters ACQUITY Arc System, a favorite of quality control laboratories the world over, has received a ...

Waters ACQUITY Arc System, a favorite of quality control laboratories the world over, has received a New Product Innovation Award from Frost & Sullivan. (Photo: Business Wire)

The Waters® ACQUITY Arc System is a liquid chromatograph (LC) that gives drug development and quality control laboratories running routine, established LC methods a single LC platform for replicating or improving the performance of their separations methods regardless of the LC platform on which they were first developed.

Until its introduction in 2015, scientists working with established methods, and who wished to improve the performance of those methods, did not have a liquid chromatograph versatile enough to bridge the gap between high performance liquid chromatography (HPLC) and UltraPerformance LC® (UPLC®). With the introduction of the ACQUITY Arc System, and its enabling Arc Multi-flow path™ technology, scientists are now able to emulate the gradient dwell volume and mixing behavior of liquid chromatographs from a variety of manufacturers without altering the method’s gradient table.

Waters formally introduced the ACQUITY Arc System in 2015 at a news conference in Beijing, China.

Janani Balasundar, Research Analyst at Frost & Sullivan, noted, “In the regulated environment in which pharmaceutical companies operate, they are by nature conservative when it comes to adopting new technologies, and they prefer “tried and true” methods especially when it comes to later stages of the drug development and commercialization process.”

Janani continued, “With the ACQUITY Arc System, Waters has given pharmaceutical companies the capability of introducing a single LC platform for their workflows for improving analytical method performance and thereby productivity while maintaining CGMP compliance.”

“On behalf of the ACQUITY Arc product team, we are thankful to Frost & Sullivan for this honor,” said Mike Yelle, Vice President – Separations, Waters Corporation. “The award recognizes the commercial success of the ACQUITY Arc System and the positive impact it is having on laboratories, in Asia and elsewhere, that are supporting business-critical analytical methods.”

About Frost & Sullivan

Frost & Sullivan, the Growth Partnership Company, works in collaboration with clients to leverage visionary innovation that addresses the global challenges and related growth opportunities that will make or break today's market participants.

Our “Growth Partnership” supports clients by addressing these opportunities and incorporating two key elements driving visionary innovation: The Integrated Value Proposition and The Partnership Infrastructure.

• The Integrated Value Proposition provides support to our clients throughout all phases of their journey to visionary innovation including: research, analysis, strategy, vision, innovation and implementation.

• The Partnership Infrastructure is entirely unique as it constructs the foundation upon which visionary innovation becomes possible. This includes our 360 degree research, comprehensive industry coverage, career best practices as well as our global footprint of more than 40 offices.

For more than 50 years, we have been developing growth strategies for the global 1000, emerging businesses, the public sector and the investment community. Is your organization prepared for the next profound wave of industry convergence, disruptive technologies, increasing competitive intensity, Mega Trends, breakthrough best practices, changing customer dynamics and emerging economies?

Contact us: Start the discussion

About Waters Corporation (www.waters.com)

Waters Corporation (NYSE:WAT) develops and manufactures advanced analytical and material science technologies for laboratory dependent organizations. For more than 50 years, the company has pioneered a connected portfolio of separations science, laboratory information management, mass spectrometry, and thermal analysis systems.

Waters, ACQUITY, UPLC, Arc Multi-Flow Path, UltraPerformance LC and ACQUITY Arc are trademarks of Waters Corporation.

EN
04/10/2016

Underlying

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on Waters Corporation

Waters Corp: 1 director

A director at Waters Corp bought 1,000 shares at 332.900USD and the significance rating of the trade was 87/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last two years clearly s...

Dave Nicoski ... (+2)
  • Dave Nicoski
  • Ross LaDuke

Vermilion Short Shots: Technically Vulnerable Stocks

Short Shots is a collection of technically vulnerable charts culled from the Negative Inflecting and Toppy columns within our Weekly Compass report or from various technical screening processes. The charts contained in this report have developed concerning technical patterns that suggest further price deterioration is likely. For these reasons Short Shots can also be a great source of ideas for investors interested in short-selling candidates.

 PRESS RELEASE

Waters Launches its Most Sensitive and Compact Clinical IVD System wit...

MONTEREY, Calif.--(BUSINESS WIRE)-- MSACL Conference 2023--Waters Corporation (NYSE:WAT) today unveiled its next generation Xevo TQ Absolute IVD mass spectrometer, expanding its family of for clinical diagnostic applications. This press release features multimedia. View the full release here: Waters' newest MassTrak IVD LC-MS/MS System featuring the Xevo TQ Absolute IVD tandem quadrupole mass spectrometer (in dark grey), is up to five times more sensitive than similar commercial mass spectrometers for quantifying analytes in samples of saliva, breath, and dried blood spots. (Photo: Business...

 PRESS RELEASE

Waters Corporation Appoints Richard Fearon to Board of Directors

MILFORD, Mass.--(BUSINESS WIRE)-- Waters™ Corporation (NYSE:WAT) today announced the appointment of Richard Fearon to its Board of Directors, effective March 27, 2023. Mr. Fearon is the former Vice Chairman and Chief Financial and Planning Officer of Eaton Corporation, a multinational power management company. “Rick’s expertise is at the intersection of financial excellence, strategic development and transformation, which are the key pillars of Waters’ growth plan. We are confident that Rick’s unique skillset will complement our Board well and we look forward to benefiting from his insights a...

 PRESS RELEASE

Waters lance le système de CLHP Alliance iS de nouvelle génération, qu...

PHILADELPHIE--(BUSINESS WIRE)-- PITTCON 2023 – Waters Corporation (NYSE:WAT) a lancé aujourd'hui , le système intelligent de CLHP de nouvelle génération, conçu pour réduire le risque de conformité en ajoutant de nouveaux niveaux de détection proactive des erreurs, de résolution des problèmes et une facilité d’utilisation. Lorsqu’il est associé au conforme et à de Waters, le système de chromatographie liquide à haute performance (CLHP) Alliance iS permet de rationaliser la tâche consistant à faire des mesures exactes et précises en détectant et éliminant les erreurs courantes jusqu’à 40 %.i C...

ResearchPool Subscriptions

Get the most out of your insights

Get in touch